Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats

Taro Mawatari, Hiromasa Miura, Hidehiko Higaki, Takaaki Moro-Oka, Kosaku Kurata, Teruo Murakami, Yukihide Iwamoto

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Menatetrenone, a vitamin K2 with four isoprene units, has been reported to improve osteoporotic bone loss. The purpose of this investigation was to clarify the effect of menatetrenone on the three-dimensional (3D) trabecular microarchitecture in ovariectomized (OVX) rats by using microcomputed tomography (MCT). Forty-two 13-week-old female rats were used and divided into four groups: the OVX (OVX + MK-4) group treated with menatetrenone, the (OVX untreated) group, the sham-operated (Sham + MK-4) group treated with menatetrenone, and the sham-operated group not treated with menatetrenone (Sham untreated) group. OVX rats were fed a calcium-deficient diet. Menatetrenone treatment was begun just after the ovariectomy, and the mean menatetrenone oral intake over the 8-week period was adjusted to 30 mg/kg BW per day. The proximal metaphyseal region of the right tibia was evaluated by dual X-ray absorptiometry (DXA) and MCT. A parametric analysis of the reconstructed trabecular volume was carried out using bone volume fractions, the fractal dimension calculated by the 3D box-counting method, and the connectivity density as determined by topological analysis. Menatetrenone significantly increased the trabecular bone volume, fractal dimension, and connectivity in the OVX + MK-4 group compared with the OVX-untreated group (p < 0.01). Our results suggest that an 8-week administration of menatetrenone protects against the loss of trabecular bone volume and its connectivity when treatment is begun just after the ovariectomy. Despite this apparent protection, it remains unknown whether it is possible to reestablish trabecular connectivity if therapeutic intervention occurs after the trabecular connectivity has been lost.

Original languageEnglish
Pages (from-to)1810-1817
Number of pages8
JournalJournal of Bone and Mineral Research
Volume15
Issue number9
DOIs
Publication statusPublished - Jan 1 2000

Fingerprint

Vitamin K 2
X-Ray Microtomography
Fractals
Ovariectomy
menatetrenone
Bone and Bones
Photon Absorptiometry
Tibia
Diet
Calcium

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats. / Mawatari, Taro; Miura, Hiromasa; Higaki, Hidehiko; Moro-Oka, Takaaki; Kurata, Kosaku; Murakami, Teruo; Iwamoto, Yukihide.

In: Journal of Bone and Mineral Research, Vol. 15, No. 9, 01.01.2000, p. 1810-1817.

Research output: Contribution to journalArticle

Mawatari, Taro ; Miura, Hiromasa ; Higaki, Hidehiko ; Moro-Oka, Takaaki ; Kurata, Kosaku ; Murakami, Teruo ; Iwamoto, Yukihide. / Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats. In: Journal of Bone and Mineral Research. 2000 ; Vol. 15, No. 9. pp. 1810-1817.
@article{5fec8be8d2b3447999ea5bbdd2523d2a,
title = "Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats",
abstract = "Menatetrenone, a vitamin K2 with four isoprene units, has been reported to improve osteoporotic bone loss. The purpose of this investigation was to clarify the effect of menatetrenone on the three-dimensional (3D) trabecular microarchitecture in ovariectomized (OVX) rats by using microcomputed tomography (MCT). Forty-two 13-week-old female rats were used and divided into four groups: the OVX (OVX + MK-4) group treated with menatetrenone, the (OVX untreated) group, the sham-operated (Sham + MK-4) group treated with menatetrenone, and the sham-operated group not treated with menatetrenone (Sham untreated) group. OVX rats were fed a calcium-deficient diet. Menatetrenone treatment was begun just after the ovariectomy, and the mean menatetrenone oral intake over the 8-week period was adjusted to 30 mg/kg BW per day. The proximal metaphyseal region of the right tibia was evaluated by dual X-ray absorptiometry (DXA) and MCT. A parametric analysis of the reconstructed trabecular volume was carried out using bone volume fractions, the fractal dimension calculated by the 3D box-counting method, and the connectivity density as determined by topological analysis. Menatetrenone significantly increased the trabecular bone volume, fractal dimension, and connectivity in the OVX + MK-4 group compared with the OVX-untreated group (p < 0.01). Our results suggest that an 8-week administration of menatetrenone protects against the loss of trabecular bone volume and its connectivity when treatment is begun just after the ovariectomy. Despite this apparent protection, it remains unknown whether it is possible to reestablish trabecular connectivity if therapeutic intervention occurs after the trabecular connectivity has been lost.",
author = "Taro Mawatari and Hiromasa Miura and Hidehiko Higaki and Takaaki Moro-Oka and Kosaku Kurata and Teruo Murakami and Yukihide Iwamoto",
year = "2000",
month = "1",
day = "1",
doi = "10.1359/jbmr.2000.15.9.1810",
language = "English",
volume = "15",
pages = "1810--1817",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats

AU - Mawatari, Taro

AU - Miura, Hiromasa

AU - Higaki, Hidehiko

AU - Moro-Oka, Takaaki

AU - Kurata, Kosaku

AU - Murakami, Teruo

AU - Iwamoto, Yukihide

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Menatetrenone, a vitamin K2 with four isoprene units, has been reported to improve osteoporotic bone loss. The purpose of this investigation was to clarify the effect of menatetrenone on the three-dimensional (3D) trabecular microarchitecture in ovariectomized (OVX) rats by using microcomputed tomography (MCT). Forty-two 13-week-old female rats were used and divided into four groups: the OVX (OVX + MK-4) group treated with menatetrenone, the (OVX untreated) group, the sham-operated (Sham + MK-4) group treated with menatetrenone, and the sham-operated group not treated with menatetrenone (Sham untreated) group. OVX rats were fed a calcium-deficient diet. Menatetrenone treatment was begun just after the ovariectomy, and the mean menatetrenone oral intake over the 8-week period was adjusted to 30 mg/kg BW per day. The proximal metaphyseal region of the right tibia was evaluated by dual X-ray absorptiometry (DXA) and MCT. A parametric analysis of the reconstructed trabecular volume was carried out using bone volume fractions, the fractal dimension calculated by the 3D box-counting method, and the connectivity density as determined by topological analysis. Menatetrenone significantly increased the trabecular bone volume, fractal dimension, and connectivity in the OVX + MK-4 group compared with the OVX-untreated group (p < 0.01). Our results suggest that an 8-week administration of menatetrenone protects against the loss of trabecular bone volume and its connectivity when treatment is begun just after the ovariectomy. Despite this apparent protection, it remains unknown whether it is possible to reestablish trabecular connectivity if therapeutic intervention occurs after the trabecular connectivity has been lost.

AB - Menatetrenone, a vitamin K2 with four isoprene units, has been reported to improve osteoporotic bone loss. The purpose of this investigation was to clarify the effect of menatetrenone on the three-dimensional (3D) trabecular microarchitecture in ovariectomized (OVX) rats by using microcomputed tomography (MCT). Forty-two 13-week-old female rats were used and divided into four groups: the OVX (OVX + MK-4) group treated with menatetrenone, the (OVX untreated) group, the sham-operated (Sham + MK-4) group treated with menatetrenone, and the sham-operated group not treated with menatetrenone (Sham untreated) group. OVX rats were fed a calcium-deficient diet. Menatetrenone treatment was begun just after the ovariectomy, and the mean menatetrenone oral intake over the 8-week period was adjusted to 30 mg/kg BW per day. The proximal metaphyseal region of the right tibia was evaluated by dual X-ray absorptiometry (DXA) and MCT. A parametric analysis of the reconstructed trabecular volume was carried out using bone volume fractions, the fractal dimension calculated by the 3D box-counting method, and the connectivity density as determined by topological analysis. Menatetrenone significantly increased the trabecular bone volume, fractal dimension, and connectivity in the OVX + MK-4 group compared with the OVX-untreated group (p < 0.01). Our results suggest that an 8-week administration of menatetrenone protects against the loss of trabecular bone volume and its connectivity when treatment is begun just after the ovariectomy. Despite this apparent protection, it remains unknown whether it is possible to reestablish trabecular connectivity if therapeutic intervention occurs after the trabecular connectivity has been lost.

UR - http://www.scopus.com/inward/record.url?scp=0033626314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033626314&partnerID=8YFLogxK

U2 - 10.1359/jbmr.2000.15.9.1810

DO - 10.1359/jbmr.2000.15.9.1810

M3 - Article

C2 - 10977000

AN - SCOPUS:0033626314

VL - 15

SP - 1810

EP - 1817

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 9

ER -